S100B and chronic obstructive pulmonary disease: HMGB1 was found to be increased in the lungs of smokers with COPD compared to non-COPD smokers or never-smokers, and a positive correlation between the serum levels of S100B and the severity of pathology was reported in a cohort of COPD patients [53].